- Home
- ATER vs PHIO Comparison
ATER vs PHIO Comparison
Compare ATER & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- PHIO
- Stock Information
- Founded
- ATER 2014
- PHIO 2011
- Country
- ATER United States
- PHIO United States
- Employees
- ATER N/A
- PHIO N/A
- Industry
- ATER Home Furnishings
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- PHIO Health Care
- Exchange
- ATER Nasdaq
- PHIO Nasdaq
- Market Cap
- ATER 10.3M
- PHIO 12.1M
- IPO Year
- ATER N/A
- PHIO N/A
- Fundamental
- Price
- ATER $0.83
- PHIO $1.48
- Analyst Decision
- ATER
- PHIO Strong Buy
- Analyst Count
- ATER 0
- PHIO 3
- Target Price
- ATER N/A
- PHIO $10.67
- AVG Volume (30 Days)
- ATER 81.0K
- PHIO 8.5M
- Earning Date
- ATER 11-13-2025
- PHIO 11-11-2025
- Dividend Yield
- ATER N/A
- PHIO N/A
- EPS Growth
- ATER N/A
- PHIO N/A
- EPS
- ATER N/A
- PHIO N/A
- Revenue
- ATER $85,668,000.00
- PHIO N/A
- Revenue This Year
- ATER N/A
- PHIO N/A
- Revenue Next Year
- ATER $7.48
- PHIO N/A
- P/E Ratio
- ATER N/A
- PHIO N/A
- Revenue Growth
- ATER N/A
- PHIO N/A
- 52 Week Low
- ATER $0.81
- PHIO $0.97
- 52 Week High
- ATER $3.50
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- ATER 25.06
- PHIO 20.31
- Support Level
- ATER $0.95
- PHIO $2.08
- Resistance Level
- ATER $0.99
- PHIO $4.19
- Average True Range (ATR)
- ATER 0.05
- PHIO 0.28
- MACD
- ATER -0.02
- PHIO -0.07
- Stochastic Oscillator
- ATER 7.28
- PHIO 4.67
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.